Hill-Rom Holdings (HRC) Tops Q2 EPS by 3c, Beats on Revenues; Boosts FY18 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Hill-Rom Holdings (HRC) & IMRIS Report Commercial Launch of New Magnetic Resonance Neurosurgical Table
May 1, 2018 4:59 PM EDTIMRIS and Hill-Rom (NYSE: HRC) have commercially launched a new multi-functional operating room (OR) table specifically designed for the IMRIS Surgical Theatre. The announcement was made during the American Academy of Neurological Surgeons (AANS) Annual Scientific Meeting this week in New Orleans.
Developed in close collaboration with clinicians, designers and engineers from IMRIS and Hill-Rom Surgical Solution's Trumpf Medical, the table integrates a new IMRIS magnetic resonance (MR) neurosurgical... More
Hill-Rom Holdings (HRC) PT Raised to $106 at Needham & Company
April 30, 2018 7:34 AM EDTNeedham & Company raised its price target on Hill-Rom Holdings (NYSE: HRC) to $106.00 (from $105.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "HRC beat consensus F2Q18 revenue and EPS. Management reiterated its FY18 revenue guidance and raised its FY18 adjusted EPS... More
Hill-Rom Holdings (HRC) Names John Groetelaars as President and CEO
April 27, 2018 6:57 AM EDTHill-Rom Holdings, Inc. (NYSE: HRC), today announced that John P. Groetelaars has been appointed president and chief executive officer of the company, effective May 14, 2018. He succeeds John J. Greisch, who previously announced his intention to retire. Mr. Groetelaars will also join Hill-Rom's board of directors.
Mr. Groetelaars is a seasoned global leader with more than 25 years of experience in the medical device industry. He most recently served as executive vice president and president of the Interventional Segment at Becton, Dickinson and Company, which he joined in December 2017 following its acquisition of C.R.... More
